SIP Trunking

Welcome to TMCnet.com
TMC Launches New Web Sites: Cable WiMAX  |  Satellite  |  Robotics  |  IT | IVR |   ITEXPO West begins in:   REGISTER NOW!
Columnists:
E-mail this page to a friend Order reprints online Print this page Bookmark this page Free magazines Free newsletters RSS-XML alerts
SIP Trunking - Ingate

[April 27, 2006]

Ultrasound used as chemotherapy sensitizer

(Science Letter Via Thomson Dialog NewsEdge)
Ultrasound could be used as a chemotherapy sensitizer.

According to recent research from the People's Republic of China, "Chemotherapy plays a very important role in cancer treatment. However, there are still some barriers in the successful use of such therapies, mainly because of the adverse side effects of the anticancer agents and due to the development of chemoresistance."


"This paper focuses on the use of ultrasound to enhance chemotherapy and to overcome drug resistance. The action of many anticancer agents can be improved with the use of ultrasonic exposure either in vitro or in vivo. Drug resistance can be circumvented using ultrasound alone. Furthermore, the reversal attributable to chemoresistance modifiers, such as verapamil and PSC 833, is augmented by ultrasound. Ultrasound-mediated chemosensitization is usually achieved via increasing intracellular drug accumulation, although other mechanisms are also involved," explained T.H. Yu and colleagues, Chongqing Medical University.

The researchers concluded, "Ultrasound also can play a role in targeted chemotherapy, releasing anticancer chemicals directly and efficiently into the lesions. However, this promising modality has not been clinically adopted so far and the reasons are discussed."

Yu and colleagues published their study in Technology in Cancer Research & Treatment (Ultrasound: A chemotherapy sensitizer. Technol Cancer Res Treat, 2006;5(1):51-60).

For additional information, contact T.H. Yu, Chongqing Medical University, Institute Ultrasound Engineering Med, Chongqing 400016, People's Republic of China.

Publisher contact information for the journal Technology in Cancer Research & Treatment is: Adenine Press, 2066 Central Avenue, Schenectady, NY 12304, USA.

Keywords: Chongqing, People's Republic of China, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anticancer Therapy, Cancer, Chemoresistance, Chemotherapy, Diagnosis, Diagnostics, Drug Resistance, Oncology, Side Effect, Targeted Therapy, Ultrasonic Therapy.

This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com.

[ Back To SIP Trunking Community's Homepage ]

E-mail this page to a friend Order reprints online Print this page Bookmark this page Free magazines Free newsletters RSS-XML alerts

Subscribe FREE to all of TMC's monthly magazines. Click here now.
TMC LOGO
Technology Marketing Corporation,
One Technology Plaza, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800; Fx: 203-866-3326
General comments: tmc@tmcnet.com. Comments about this site: webmaster@tmcnet.com.
About   Contact  Advertise
Technology Marketing Corp. 1997-2008 Copyright. Privacy Policy Sitemap
Advanced